David Rosenbloom
Profiles

David L. Rosenbloom, PhD

Professor, Health Law, Policy & Management - Boston University School of Public Health

Biography

David is currently Professor of Public Health at the Boston University School of Public Health where he focuses on US and international health policy and issues relating to substance use disorders. His more than 40 year career spans the public, private, not for profit and academic health sectors. From 1975-1983, as Commissioner of Health and Hospitals for the City of Boston he was the city’s public health officer and CEO of the city’s public delivery system, including Boston City Hospital, 22 neighborhood health centers, and the emergency medical system. From 1984 to 1988 David was Vice President and then President of Health Data Institute, Inc, a company that pioneered the clinical analysis of medical claims data and developed managed care tools and techniques used throughout the country today. He has conducted, published research and led national community based demonstration projects in addiction prevention, treatment and policy. He has also led development of web/mobile based interventions to help individuals quit smoking, assess their risk for alcohol and drug related health problems, and reduce unhealthy drinking among veterans returning from combat.

Trained in political science (MIT, PhD 1970) he conducted some of the first research on the development of the professional campaign management industry in the US, The Election Men (Quadrangle Press, NY, 1973) He was the founder and Director of Join Together, a program of BUSPH to assist communities throughout the country develop leadership and effective strategies to address addiction and gun violence problems. He served as a member of the National Advisory Council for NIDA from 1999-2003. David was a Director of the Spaulding Rehabilitation Hospital from1984 to 2013 and Chaired its Board from 2006-2009. He co-founded and Chaired from 1989 to 1996 Community Medical Alliance, Inc. an HMO for people with catastrophic medical conditions. He was Chairman of Quitnet.com from 2000-2005 and has served as a Director of Stop Handgun Violence since 1995. In 2015 he helped found and serves as a Director of the Police Assisted Addiction Recovery Initiative. He is the current Board Chair of the Boston Foundation for Sight.

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University

Education

  • Massachusetts Institute of Technology, PhD Field of Study: Political Science
  • Colgate University, BA Field of Study: Political Science

Classes Taught

  • SPHPH719
  • SPHPM760

Publications

  • Published on 3/7/2022

    Newberger NG, Yeager S, Livingston NA, Enggasser JL, Brief DJ, Litwack S, Helmuth E, Roy M, Rosenbloom D, Keane TM. Life satisfaction following treatment-related reductions in alcohol use and PTSD symptoms: Results from VetChange. Psychol Trauma. 2022 Mar 07. PMID: 35254847.

    Read At: PubMed
  • Published on 10/29/2021

    Choi S, Stein MD, Raifman J, Rosenbloom D, Clark JA. Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy. Drug Alcohol Depend. 2021 12 01; 229(Pt A):109162. PMID: 34768053.

    Read At: PubMed
  • Published on 8/10/2021

    Choi S, Rosenbloom D, Stein MD, Raifman J, Clark JA. Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review. J Addict Med. 2021 Aug 10. PMID: 34380985.

    Read At: PubMed
  • Published on 8/7/2021

    Choi S, Stein MD, Raifman J, Rosenbloom D, Clark JA. Motherhood, pregnancy and gateways to intervene in substance use disorder. Health Soc Care Community. 2022 Jul; 30(4):e1268-e1277. PMID: 34363426.

    Read At: PubMed
  • Published on 2/2/2021

    Davoust M, Grim V, Hunter A, Jones DK, Rosenbloom D, Stein MD, Drainoni ML. Examining the implementation of police-assisted referral programs for substance use disorder services in Massachusetts. Int J Drug Policy. 2021 06; 92:103142. PMID: 33546937.

    Read At: PubMed
  • Published on 1/29/2021

    Livingston NA, Simpson T, Lehavot K, Ameral V, Brief DJ, Enggasser J, Litwack S, Helmuth E, Roy M, Rosenbloom D, Keane TM. Differential alcohol treatment response by gender following use of VetChange. Drug Alcohol Depend. 2021 04 01; 221:108552. PMID: 33556659.

    Read At: PubMed
  • Published on 12/31/2020

    Formica SW, Waye KM, Benintendi AO, Yan S, Bagley SM, Beletsky L, Carroll JJ, Xuan Z, Rosenbloom D, Apsler R, Green TC, Hunter A, Walley AY. Characteristics of post-overdose public health-public safety outreach in Massachusetts. Drug Alcohol Depend. 2021 02 01; 219:108499. PMID: 33421800.

    Read At: PubMed
  • Published on 12/11/2020

    Enggasser JL, Livingston NA, Ameral V, Brief DJ, Rubin A, Helmuth E, Roy M, Solhan M, Litwack S, Rosenbloom D, Keane TM. Public implementation of a web-based program for veterans with risky alcohol use and PTSD: A RE-AIM evaluation of VetChange. J Subst Abuse Treat. 2021 03; 122:108242. PMID: 33509419.

    Read At: PubMed
  • Published on 7/1/2020

    Rosenbloom DL, Lewis DC. Health Professionals Should be Involved in Shaping Substance Use Disorder Policy. J Addict Med. 2020 Jul/Aug; 14(4):275-276. PMID: 31688148.

    Read At: PubMed
  • Published on 5/7/2020

    Schreiner AM, Livingston NA, Heilman M, Lynch T, Vittorio L, Brief DJ, Rubin A, Enggasser JL, Roy M, Solhan M, Helmuth E, Rosenbloom D, Keane TM. Understanding motives for and against hazardous drinking and change among returning veterans. Psychol Serv. 2021 Nov; 18(4):523-532. PMID: 32378932.

    Read At: PubMed

News & In the Media